We originally explained this feature with the observation that both mutations affect the same pathway, as CEBPA is mutated in CEBPAN/C AML and is repressed by RUNX1/ETO in t(8;21) AML [24, 25]. Here, RUNX1 is linked to acute myeloid leukemia.